Recent Advances in the Treatment and Prevention of Venous Thromboembolism in Cancer Patients: Role of the Direct Oral Anticoagulants and Their Unique Challenges

F1000Research - United Kingdom
doi 10.12688/f1000research.18673.1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

F1000 Research Ltd

Related search

Recent Advances in the Treatment of Venous Thromboembolism in the Era of the Direct Oral Anticoagulants

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2017English

Potential Role of New Anticoagulants for Prevention and Treatment of Venous Thromboembolism in Cancer Patients

Vascular Health and Risk Management
2013English

Hypoalbuminemia for the Prediction of Venous Thromboembolism and Treatment of Direct Oral Anticoagulants in Metastatic Gastric Cancer Patients

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2019English

Development of Treatment of Cancer-Associated Venous Thromboembolism With Direct Oral Anticoagulants

The Japanese Journal of Phlebology
2020English

Recent Advances in the Treatment of Venous Thromboembolism

Japanese Journal of Neurosurgery
SurgeryNeurology
2018English

The Treatment of Venous Thromboembolism With New Oral Anticoagulants

Italian Journal of Medicine
Medicine
2013English

Prevention and Treatment of Venous Thromboembolism in Patients With Cancer

Therapeutic Advances in Hematology
Hematology
2011English

Prevention and Treatment of Venous Thromboembolism in Patients With Cancer

Canadian Pharmacists Journal
Pharmaceutical SciencePharmacy
2012English

Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy